(Q52273808)

28 April 2018

title

Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. (English)

1 reference

28 April 2018

1 reference

1

Cattran DC

1 reference

28 April 2018

author name string

Pei Y

2

1 reference

28 April 2018

Greenwood CM

3

1 reference

28 April 2018

Ponticelli C

4

1 reference

28 April 2018

Passerini P

5

1 reference

28 April 2018

Honkanen E

6

1 reference

28 April 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

28 April 2018

published in

Kidney International

1 reference

28 April 2018

volume

51

1 reference

28 April 2018

issue

3

1 reference

28 April 2018

page(s)

901-907

1 reference

28 April 2018

https://scigraph.springernature.com/pub.10.1038/ki.1997.127

exact match

0 references

cites work

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Membranous glomerulonephritis. Evolution of clinical and pathologic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Membranous glomerulonephritis: long-term serial observations on clinical course and morphology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Idiopathic membranous glomerulonephritis: aspects of geographical differences

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Membranous Nephropathy: Its Relative Benignity in Women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Membranous nephropathy: predictors of terminal renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Epidemiology of primary glomerular diseases in a French region. Variations according to period and age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Clinical course and outcome of idiopathic membranous nephropathy in Japanese children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Strong association between idiopathic membranous nephropathy and HLA-DRW3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Analysis of complement C4 loci in Caucasoids and Japanese with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Therapy for idiopathic membranous nephropathy: tailoring the choice by decision analysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Membranous nephropathy--still a treatment dilemma.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Idiopathic membranous nephropathy--to treat or not to treat?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Prognostic indicators in patients presenting with the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Validation techniques for logistic regression models

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Primary sclerosing cholangitis: refinement and validation of survival models

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.127

7 January 2021

Identifiers

DOI

10.1038/KI.1997.127

1 reference

28 April 2018

Dimensions Publication ID

1038373905

0 references

1 reference

28 April 2018